Ridgewood Investments LLC Gilead Sciences, Inc. Transaction History

Ridgewood Investments LLC

$201 Million
Q3 2024

A detailed history of Ridgewood Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ridgewood Investments LLC holds 13,372 shares of GILD stock, worth $1.24 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

13,372

Previous 14,798 9.64%

Holding current value

$1.24 Million

Previous $1.02 Million 10.34%

% of portfolio

0.56%

Previous 0.5%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$66.59 - $83.99 $94,957 - $119,769	-1,426 Reduced 9.64%	13,372 $1.12 Million
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $504,631 - $582,384	7,991 Added 117.39%	14,798 $1.02 Million
Q1 2024 Apr 10, 2024	BUY	$71.58 - $87.29 $487,245 - $594,183	6,807 New	6,807 $498,000
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $44,769 - $51,066	-589 Reduced 76.59%	180 $13,000
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $891,538 - $1.02 Million	-11,532 Reduced 93.75%	769 $63,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $672,557 - $965,560	-10,792 Reduced 46.73%	12,301 $0
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $476 - $544	-8 Reduced 0.03%	23,093 $1.43 Million
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $57 - $65	-1 Reduced -0.0%	23,101 $1.43 Million
Q1 2022 Apr 11, 2022	SELL	$57.92 - $72.58 $27,512 - $34,475	-475 Reduced 2.01%	23,102 $1.37 Million
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $30,104 - $34,168	464 Added 2.01%	23,577 $1.71 Million
Q3 2021 Oct 20, 2021	SELL	$67.69 - $73.03 $609 - $657	-9 Reduced 0.04%	23,113 $1.61 Million
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $269,874 - $294,876	4,252 Added 22.53%	23,122 $1.59 Million
Q1 2021 Apr 27, 2021	BUY	$60.0 - $68.46 $357,600 - $408,021	5,960 Added 46.17%	18,870 $1.22 Million
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $396,508 - $498,540	6,385 Added 97.85%	12,910 $816,000
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $44,633 - $51,828	-617 Reduced 8.64%	6,525 $502,000
Q1 2020 Apr 27, 2020	SELL	$62.63 - $80.22 $652,604 - $835,892	-10,420 Reduced 59.33%	7,142 $534,000
Q4 2019 Jan 15, 2020	BUY	$61.62 - $67.78 $117,447 - $129,188	1,906 Added 12.17%	17,562 $1.14 Million
Q3 2019 Oct 23, 2019	BUY	$62.51 - $69.0 $154,649 - $170,706	2,474 Added 18.77%	15,656 $992,000
Q2 2019 Jul 12, 2019	BUY	$61.87 - $69.38 $308,855 - $346,344	4,992 Added 60.95%	13,182 $891,000
Q1 2019 Apr 15, 2019	BUY	$62.53 - $70.05 $106,363 - $119,155	1,701 Added 26.21%	8,190 $532,000
Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $34,927 - $38,670	490 Added 8.17%	6,489 $501,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $32,439 - $37,840	500 Added 9.09%	5,999 $425,000
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $2,205 - $2,573	34 Added 0.62%	5,499 $390,000
Q1 2018 Apr 17, 2018	BUY	$72.84 - $88.8 $31,175 - $38,006	428 Added 8.5%	5,465 $412,000
Q4 2017 Jan 12, 2018	BUY	$71.15 - $83.52 $52,864 - $62,055	743 Added 17.3%	5,037 $361,000
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $309,640 - $367,008	4,294	4,294 $348,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ridgewood Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ridgewood Investments LLC with notifications on news.

Account

Ridgewood Investments LLC Gilead Sciences, Inc. Transaction History